Your browser doesn't support javascript.
loading
The Exeter Activity Unlimited statement on physical activity and exercise for cystic fibrosis: methodology and results of an international, multidisciplinary, evidence-driven expert consensus.
Williams, Craig A; Barker, Alan R; Denford, Sarah; van Beurden, Samantha B; Bianchim, Mayara S; Caterini, Jessica E; Cox, Narelle S; Mackintosh, Kelly A; McNarry, Melitta A; Rand, Sarah; Schneiderman, Jane E; Wells, Greg D; Anderson, Peter; Beever, Daniel; Beverley, Z; Buckley, Ronan; Button, Brenda; Causer, Adam J; Curran, Máire; Dwyer, Tiffany J; Gordon, Warren; Gruet, Mathieu; Harris, Ryan A; Hatziagorou, Elpis; Erik Hulzebos, H J; Kampouras, Asterios; Morrison, Lisa; Cámara, Marietta N; Reilly, Clare M; Sawyer, Abbey; Saynor, Zoe L; Shelley, James; Spencer, Grace; Stanford, Gemma E; Urquhart, Don S; Young, Rachel; Tomlinson, Owen W.
Affiliation
  • Williams CA; Children's Health and Exercise Research Centre, Sport and Health Science, 3286University of Exeter, Exeter, UK.
  • Barker AR; Royal Devon and Exeter NHS Foundation Trust Hospital, Exeter, UK.
  • Denford S; Children's Health and Exercise Research Centre, Sport and Health Science, 3286University of Exeter, Exeter, UK.
  • van Beurden SB; 1980Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol, Bristol, UK.
  • Bianchim MS; Population Health Sciences, Bristol Medical School, 1980University of Bristol, Bristol, UK.
  • Caterini JE; School of Psychological Science, 1980University of Bristol, Bristol, UK.
  • Cox NS; College of Medicine and Health, 3286University of Exeter, Exeter, UK.
  • Mackintosh KA; 7622University of Stirling, NMAHP Research Unit, University of Stirling, Stirling, UK.
  • McNarry MA; Translational Medicine, The Hospital for Sick Children, Toronto, Canada.
  • Rand S; School of Medicine, Queen's University, Kingston, Canada.
  • Schneiderman JE; Respiratory Research @ Alfred, Department of Immunology and Pathology, 2541Monash University, Melbourne, Australia.
  • Wells GD; Institute for Breathing and Sleep, Melbourne, Australia.
  • Anderson P; Applied Sports, Technology, Exercise and Medicine (A-STEM) Research Centre, Department of Sport and Exercise Sciences, 7759Swansea University, Swansea, UK.
  • Beever D; Applied Sports, Technology, Exercise and Medicine (A-STEM) Research Centre, Department of Sport and Exercise Sciences, 7759Swansea University, Swansea, UK.
  • Beverley Z; Physiotherapy, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Buckley R; Division of Respiratory Medicine, Hospital for Sick Children, Toronto, Canada.
  • Button B; Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, Canada.
  • Causer AJ; Translational Medicine, The Hospital for Sick Children, Toronto, Canada.
  • Curran M; 59842Royal Hospital for Children, Glasgow, UK.
  • Dwyer TJ; School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Gordon W; Adult Cystic Fibrosis Unit, 4964Royal Brompton and Harefield Hospitals, Guy's and St Thomas's NHS Foundation Trust, London, UK.
  • Gruet M; National Referral Centre for Adult Cystic Fibrosis, St Vincent's University Hospital, Dublin, Republic Of Ireland.
  • Harris RA; Faculty of Medicine Nursing and Health Sciences, 2541Monash University, Melbourne, Australia.
  • Hatziagorou E; Department of Respiratory Medicine, 5392Alfred Health, Melbourne, Australia.
  • Erik Hulzebos HJ; Department for Health, 1555University of Bath, Bath, UK.
  • Kampouras A; School of Allied Health, 8808University of Limerick, Limerick, Republic Of Ireland.
  • Morrison L; University Hospital Limerick, Limerick, Republic Of Ireland.
  • Cámara MN; Health Research Institute, 8808University of Limerick, Limerick, Republic Of Ireland.
  • Reilly CM; Discipline of Physiotherapy, Sydney School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Sawyer A; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown, Australia.
  • Saynor ZL; 59842Royal Hospital for Children, Glasgow, UK.
  • Shelley J; 27017University of Toulon, IAPS Laboratory, Toulon, France.
  • Spencer G; Georgia Prevention Institute, Department of Medicine, 1421Augusta University, Augusta GA, United States Of America.
  • Stanford GE; Paediatric Pulmonology and CF Unit, 3rd Paediatric Department, 37782Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Urquhart DS; Department of Pediatrics, Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Young R; Paediatric Pulmonology and CF Unit, 3rd Paediatric Department, 37782Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Tomlinson OW; Paediatric Department, 424 General Military Hospital, Thessaloniki, Greece.
Chron Respir Dis ; 19: 14799731221121670, 2022.
Article de En | MEDLINE | ID: mdl-36068015
ABSTRACT

BACKGROUND:

The roles of physical activity (PA) and exercise within the management of cystic fibrosis (CF) are recognised by their inclusion in numerous standards of care and treatment guidelines. However, information is brief, and both PA and exercise as multi-faceted behaviours require extensive stakeholder input when developing and promoting such guidelines.

METHOD:

On 30th June and 1st July 2021, 39 stakeholders from 11 countries, including researchers, healthcare professionals and patients participated in a virtual conference to agree an evidence-based and informed expert consensus about PA and exercise for people with CF. This consensus presents the agreement across six themes (i) patient and system centred outcomes, (ii) health benefits, iii) measurement, (iv) prescription, (v) clinical considerations, and (vi) future directions. The consensus was achieved by a stepwise process, involving (i) written evidence-based synopses; (ii) peer critique of synopses; (iii) oral presentation to consensus group and peer challenge of revised synopses; and (iv) anonymous voting on final proposed synopses for adoption to the consensus statement.

RESULTS:

The final consensus document includes 24 statements which surpassed the consensus threshold (>80% agreement) out of 30 proposed statements.

CONCLUSION:

This consensus can be used to support health promotion by relevant stakeholders for people with CF.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Mucoviscidose Type d'étude: Guideline Limites: Humans Langue: En Journal: Chron Respir Dis Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Mucoviscidose Type d'étude: Guideline Limites: Humans Langue: En Journal: Chron Respir Dis Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni